Health Sciences Authority Executive and Leadership Team

Mimi MayLing, the Chief Executive Officer at Health Sciences Authority, directs the overarching strategic vision for national health product regulation. Overseeing the integration of medical device safety, therapeutic product efficacy, and forensic laboratory services, the Chief Executive Officer ensures alignment with national public health objectives. Mimi MayLing manages high-level interactions with international regulatory bodies to harmonize standards and elevate regional safety protocols. By driving organizational efficiency across the blood bank and analytical divisions, the Chief Executive Officer maintains the integrity of the national health ecosystem. This leadership role involves constant evaluation of emerging health technologies to mitigate risks for the general public. Through proactive policy development and resource allocation, the Chief Executive Officer secures the operational stability of the agency. Ultimately, MayLing fosters a culture of scientific rigor and public trust, ensuring that all health products meet stringent quality benchmarks before reaching the Singapore market.

Sebastian Pang, the Deputy Director at Health Sciences Authority, manages the complex regulatory framework governing therapeutic products and pharmaceutical safety. Overseeing the evaluation of clinical data, the Deputy Director ensures that all medicines entering the market meet strict efficacy and quality standards. Sebastian Pang coordinates with healthcare providers and manufacturers to streamline approval processes while maintaining robust safety monitoring systems. This leadership role involves analyzing global pharmaceutical trends to inform local policy adjustments and enhance public health outcomes. By optimizing the review cycle for new therapeutic agents, the Deputy Director accelerates access to essential treatments for the population. Pang drives the implementation of advanced pharmacovigilance strategies to detect and manage potential risks associated with health products. Through consistent engagement with industry stakeholders, the Deputy Director upholds the reputation of the agency as a leader in regional health regulation and safety assurance.

Alfred Kwek, the Deputy Director at Health Sciences Authority, leads the operational management of the national blood bank and related transfusion services. Overseeing the collection, processing, and distribution of blood products, the Deputy Director ensures a stable and safe supply for the entire healthcare system. Alfred Kwek implements advanced laboratory protocols to maintain the highest standards of blood safety and quality control. This leadership role involves managing critical infrastructure and logistics to support emergency medical needs across the nation. By optimizing donor recruitment programs and blood inventory management, the Deputy Director sustains the operational readiness of the blood bank. Kwek directs the integration of new diagnostic technologies to enhance the screening process for blood-borne pathogens. Through rigorous oversight of transfusion safety standards, the Deputy Director protects patient health and supports the broader mission of the agency in delivering reliable medical services to the public.

Liong Ng, the Deputy Director at Health Sciences Authority, architects the regulatory strategy for medical devices and health technology innovation. Overseeing the classification and approval of diverse medical equipment, the Deputy Director ensures that all devices demonstrate safety and performance before clinical deployment. Liong Ng collaborates with manufacturers to navigate complex regulatory pathways while maintaining strict compliance with international standards. This leadership role involves assessing the impact of digital health tools and wearable devices on the existing regulatory landscape. By fostering innovation through clear guidance and efficient review processes, the Deputy Director supports the adoption of cutting-edge medical technology. Ng drives the development of post-market surveillance programs to monitor device performance in real-world clinical settings. Through strategic partnerships with global health authorities, the Deputy Director enhances the agency's capacity to manage the rapid evolution of medical device technology and ensure patient safety.

Cheong Goh, the Deputy Director at Health Sciences Authority, directs the forensic and analytical laboratory services that support national law enforcement and public health investigations. Overseeing the application of advanced scientific techniques, the Deputy Director ensures the accuracy and reliability of forensic evidence provided to the justice system. Cheong Goh manages the laboratory's operational capacity, including the deployment of sophisticated analytical instrumentation for toxicology and chemical analysis. This leadership role involves maintaining accreditation standards and fostering continuous improvement in forensic methodologies. By coordinating with legal and medical authorities, the Deputy Director facilitates the timely resolution of complex cases requiring scientific expertise. Goh drives the implementation of new analytical protocols to address emerging threats in public safety and health. Through rigorous quality management and technical oversight, the Deputy Director upholds the scientific integrity of the agency's forensic services and contributes to the overall safety of the community.

Yuhua Tan, the Deputy Director at Health Sciences Authority, manages the regulatory oversight of health supplements and traditional medicines. Overseeing the assessment of product safety and labeling compliance, the Deputy Director ensures that consumers receive accurate information regarding the quality and ingredients of these products. Yuhua Tan coordinates with industry stakeholders to enforce standards that prevent the sale of adulterated or unsafe health supplements. This leadership role involves developing public education initiatives to promote the safe use of traditional medicines and supplements. By monitoring market trends and conducting regular product testing, the Deputy Director identifies and mitigates potential health risks to the general public. Tan drives the refinement of regulatory policies to balance consumer access with rigorous safety requirements. Through proactive enforcement actions and clear communication, the Deputy Director protects the population from substandard health products and maintains the credibility of the national regulatory framework.

Yunshi Wang, the Deputy Director at Health Sciences Authority, leads the international collaboration and regulatory harmonization efforts for the agency. Overseeing the engagement with global health organizations, the Deputy Director ensures that national regulatory practices align with international best practices and emerging standards. Yunshi Wang facilitates the exchange of technical information and regulatory intelligence to enhance the agency's capacity to address global health challenges. This leadership role involves representing the agency in international forums to influence policy development and promote regional safety standards. By building strong partnerships with other national regulatory bodies, the Deputy Director strengthens the global network of health product safety. Wang drives the implementation of collaborative review processes to streamline the approval of innovative health products. Through strategic international outreach, the Deputy Director elevates the agency's global standing and ensures that the national regulatory system remains robust, transparent, and responsive to global health trends.

Lisa Tan, the Deputy Director at Health Sciences Authority, manages the corporate strategy and organizational development initiatives for the agency. Overseeing the alignment of internal resources with the agency's mission, the Deputy Director ensures that all departments possess the necessary tools and talent to achieve regulatory excellence. Lisa Tan coordinates cross-functional projects to improve operational efficiency and streamline internal processes. This leadership role involves developing human capital strategies to attract and retain scientific expertise within the organization. By optimizing the use of digital infrastructure and data management systems, the Deputy Director supports the agency's ability to make evidence-based decisions. Tan drives the implementation of performance management frameworks to track progress against strategic goals. Through effective resource planning and organizational design, the Deputy Director sustains the agency's capacity to fulfill its mandate of protecting public health and ensuring the safety of health products across the nation.

Damian Chuah, the Deputy Director at Health Sciences Authority, directs the risk assessment and safety monitoring programs for all regulated health products. Overseeing the collection and analysis of adverse event reports, the Deputy Director identifies potential safety signals that require regulatory intervention. Damian Chuah coordinates with clinical experts and manufacturers to investigate safety concerns and implement necessary risk mitigation measures. This leadership role involves communicating safety information to healthcare providers and the public to ensure informed decision-making. By utilizing advanced data analytics, the Deputy Director detects patterns in product performance that inform policy updates and safety alerts. Chuah drives the development of proactive safety strategies to prevent harm before it occurs. Through rigorous evaluation of post-market data, the Deputy Director maintains the safety profile of the national health product market and reinforces the agency's commitment to protecting the health and well-being of the population.

Na Lim, the Deputy Director at Health Sciences Authority, manages the quality assurance and regulatory compliance programs for the agency's laboratory and manufacturing oversight functions. Overseeing the implementation of quality management systems, the Deputy Director ensures that all laboratory testing and regulatory processes adhere to international standards. Na Lim coordinates internal audits and inspections to verify compliance with established protocols and safety requirements. This leadership role involves fostering a culture of quality and continuous improvement across all technical divisions. By identifying gaps in operational processes, the Deputy Director implements corrective actions to enhance the reliability of scientific data and regulatory decisions. Lim drives the integration of quality metrics into the agency's performance reporting to ensure transparency and accountability. Through consistent monitoring and rigorous oversight, the Deputy Director maintains the high standards of quality and integrity that define the agency's role in safeguarding public health and safety.